Biggest News Aggregation in the World
📰 Offering Compassionate Use News

Offering Compassionate Use News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Offering Compassionate Use. Real-time updates on events, politics, business and more.

Telix Pharmaceuticals Limited: Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application
United States Kyahn Williamson Cdx Zircaix James Stonecypher Australian Therapeutic Goods Administration Telix Pharmaceuticals Limited

First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a United States (U.S.) expanded access program (EAP, ClinicalTrials.gov ID: NCT06090331) for TLX250-CDx (89Zr-DFO-girentuximab). TLX250-CDx is the Company's first-in-class, non-invasive investigational positron emission tomography (PET) imaging agent in clear cell renal cell carcinoma (ccRCC).
United States United Kingdom Mary Jessel Kyahn Williamson John Leahy Drug Administration
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science